Amwell (previously known as American Well) is the developer of a telehealth platform connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/20/2020 | Series C | $617MM | $xx.xx | $102.71B | Adip, Allianz X, Anthem, Cito Ventures, Echo Health Ventures, Hanaco Venture Capital, Inventure Partners, Martin Ventures, Mckesson Ventures, Philips, Sv Health Investors, Teva Pharmaceutical Industries, Waterline Ventures, Westway Capital | |
Price per Share
$xx.xx
Shares Outstanding
13,711,111
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.1x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adip, Allianz X, Anthem, Cito Ventures, Echo Health Ventures, Hanaco Venture Capital, Inventure Partners, Martin Ventures, Mckesson Ventures, Philips, Sv Health Investors, Teva Pharmaceutical Industries, Waterline Ventures, Westway Capital
|
||||||
10/08/2008 | Series B | $25MM | $xx.xx | $39.81B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
833,334
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.1x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
02/07/2007 | Series A | $32MM | $xx.xx | $12.48B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,200,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.1x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|